Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-071348
Filing Date
2024-03-19
Accepted
2024-03-19 16:28:12
Documents
9
Effectiveness Date
2024-03-19

Document Format Files

Seq Description Document Type Size
1 S-3ASR d809857ds3asr.htm S-3ASR 224538
2 EX-1 d809857dex1.htm EX-1 119556
3 EX-5 d809857dex5.htm EX-5 5410
4 EX-23.A d809857dex23a.htm EX-23.A 2111
5 EX-25 d809857dex25.htm EX-25 42210
6 EX-FILING FEES d809857dexfilingfees.htm EX-FILING FEES 34525
7 GRAPHIC g809857dsp65.jpg GRAPHIC 3197
8 GRAPHIC g809857dsp65a.jpg GRAPHIC 73422
9 GRAPHIC g809857g68m67.jpg GRAPHIC 31412
  Complete submission text file 0001193125-24-071348.txt   575338
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-278066 | Film No.: 24763803
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)